Ulinastatin, a protease inhibitor, may inhibit allogeneic blood transfusion-associated pro-inflammatory cytokines and systemic inflammatory response syndrome and improve postoperative recovery

Blood Transfusion

Volumn 12, Issue SUPPL.1, 2014, Pages

  Shu, Haihua ^a   Liu, Kuanzhi ^a   He, Qiulan ^a   Zhong, Fei ^b,c   Yang, Lu ^a   Li, Qiaobo ^a   Liu, Weifeng ^a   Ye, Fang ^a   Huang, Wenqi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Guangzhou Municipal Center for Disease Control and Prevention   (China)

Author keywords

Blood transfusion; Hepatic resection; Pro inflammatory cytokines; Protease inhibitor; Systemic inflammatory response syndrome

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BLOOD TRANSFUSION; COLLOIDS; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HEPATECTOMY; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; ISOTONIC SOLUTIONS; LENGTH OF STAY; MALE; MIDDLE AGED; PLASMA; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROSPECTIVE STUDIES; PROTEASE INHIBITORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84893911447     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0224-12     Document Type: Article

References (40)

1. Ko ch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39.
2. Shander A. Emerging risks and outcomes of blood transfusion in surgery. Semin Hematol 2004; 41: 117-24.
3. Va mvakas EC, Blajchman M.A. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21: 327-48.
4. Na politano LM. Current status of blood component therapy in surgical critical care. Curr Opin Crit Care 2004; 10: 311-7.
5. Ed gren G, Kamper-Jorgensen M, Eloranta S, et al. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion 2010; 50: 1185-95.
6. va n de Watering L, Lorinser J, Versteegh M, et al. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 2006; 46: 1712-8.
7. Sp arrow RL, Patton KA. Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 2004; 44: 722-30.
8. Za llen G, Moore EE, Ciesla DJ, et al. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock 2000; 13: 29-33.
9. Ma ier B, Lefering R, Lehnert M, et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 2007; 28: 668-74.
10. J onsson-Berling BM, Ohlsson K, Rosengren M. Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine. Biol Chem Hoppe Seyler 1989; 370: 1157-61.
11. H irose J, Ozawa T, Miura T, et al. Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins. Biol Pharm Bull 1998; 21: 651-6.
12. J in X, Deng L, Li H, et al. Identification and characterization of a serine protease inhibitor with two trypsin inhibitor-like domains from the human hookworm Ancylostoma duodenale. Parasitol Res 2011; 108: 287-95.
13. N ishiyama T, Aibiki M, Hanaoka K. The effect of ulinastatin, a human protease inhibitor, on the transfusion-induced increase of plasma polymorphonuclear granulocyte elastase. Anesth Analg 1996; 82: 108-12.
14. N ishiyama T, Hanaoka K. Do the effects of a protease inhibitor, ulinastatin, on elastase release by blood transfusion depend on interleukin 6? Crit Care Med 2001; 29: 2106-10.
15. S ablotzki A, Dehne MG, Friedrich I, et al. Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery. Eur J Med Res 2003; 8: 71-6.
16. B ilgin YM, Brand A. Transfusion-related immunomodulation: a second hit in an inflammatory cascade? Vox Sang 2008; 95: 261-71.
17. K arasawa S, Uehara K, Yokota T, Nomoto Y. Changes in serum concentrations of cytokines by ulinastatin and blood transfusion in upper abdominal surgery. (in Japanese). J Clin Anesthes 1996; 20: 1169-75.
18. B ingyang J, Jinping L, Mingzheng L, et al. Effects of urinary protease inhibitor on inflammatory response during onpump coronary revascularisation. Effect of ulinastatin on inflammatory response. J Cardiovasc Surg (Torino) 2007; 48: 497-503.
19. B one RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
20. B one RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med 1992; 20: 724-6.
21. D unne JR, Malone DL, Tracy JK, Napolitano LM. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect (Larchmt) 2004; 5: 395-404.
22. W ang XY, Niu CL, Zhang L, et al. [Effect of enteral nutrition on liver function and inflammatory response after abdominal operation in patients complicated with liver dysfunction]. (In Chinese). Zhonghua Wei Chang Wai Ke Za Zhi 2011; 14: 336-9.
23. M ommsen P, Andruszkow H, Fromke C, et al. Effects of accidental hypothermia on posttraumatic complications and outcome in multiple trauma patients. Injury 2013; 44: 86-90.
24. T sujimoto H, Ono S, Takahata R, et al. Systemic inflammatory response syndrome as a predictor of anastomotic leakage after esophagectomy. Surg Today 2011; 42: 141-6.
25. F ransen E, Maessen J, Dentener M, et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116: 1233-9.
26. W en D, Zhou XL, Li JJ, et al. Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-alpha and matrix metalloproteinase-9 in aortic dissection. Clin Chim Acta 2012; 413: 198-202.
27. M uller M, Scheel O, Lindner B, et al. The role of membranebound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. J Endotoxin Res 2003; 9: 181-6.
28. H anazaki K, Monma T, Hiraguri M, et al. Cytokine response to human liver ischemia-reperfusion injury during hepatectomy: marker of injury or surgical stress? Hepatogastroenterology 2001; 48: 188-92.
29. C ohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-91.
30. Mukaida N, Matsumoto T, Yokoi K, et al.Inhibition of neutrophil-mediated acute inflammation injury by an antibody against interleukin-8 (IL-8). Inflamm Res 1998; 47 (Suppl 3): S151-7.
31. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: when is it not safe? Crit Care Med 2003; 31: S687-97.
32. D inarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-147.
33. I noue K, Takano H, Shimada A, et al. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 2005; 67: 673-80.
34. K elk P, Claesson R, Hanstrom L, et al. Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2005; 73: 453-8.
35. S impson JL, Gibson PG, Wark PA. Optimization of sputumprocessing methods for the measurement of interleukin-5: effects of protease inhibition. Respirology 2002; 7: 111-6.
36. I namo Y, Okubo T, Wada M, et al. Intravenous ulinastatin therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis in pediatric patients. Three case reports. Int Arch Allergy Immunol 2002; 127: 89-94.
37. I noue K, Takano H, Yanagisawa R, Yoshikawa T. Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharide. J Clin Biochem Nutr 2008; 43: 139-42.
38. I noue K, Takano H. Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders. Expert Opin Investig Drugs 2010; 19: 513-20.
39. R ibeiro JK, Cunha DD, Fook JM, Sales MP. New properties of the soybean trypsin inhibitor: Inhibition of human neutrophil elastase and its effect on acute pulmonary injury. Eur J Pharmacol 2010; 644: 238-44.
40. J onsson-Berling BM, Ohlsson K. Distribution and elimination of intravenously injected urinary trypsin inhibitor. Scand J Clin Lab Invest 1991; 51: 549-57.